Get started
Author

Robert Maganini

Effects of stellate-ganglion block on hot flushes and night awakenings in survivors of breast cancer: a pilot study
2008 · Eugene G Lipov, Jaydeep R Joshi, et al. · The Lancet Oncology · 104
Phase 2 Open-Label Trial Investigating Percutaneous Laser Ablation for Treatment of Early-Stage Breast Cancer: MRI, Pathology, and Outcome Correlations
2018 · Barbara Schwartzberg, John Lewin, et al. · Annals of Surgical Oncology · 53
PDF
Upgrade rate of core biopsy-determined atypical ductal hyperplasia by open excisional biopsy
2001 · Robert O Maganini, David A Klem, et al. · The American Journal of Surgery · 38
The Clinical Utility of a 7-Gene Biosignature on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery: An Updated Analysis of the DCISionRT® PREDICT Study
2024 · Chirag Shah, Pat Whitworth, et al. · Annals of Surgical Oncology · 22
High concordance of 70‐gene recurrence risk signature and 80‐gene molecular subtyping signature between core needle biopsy and surgical resection specimens in early‐stage breast cancer
2021 · Jennifer A. Crozier, Julie Barone, et al. · Journal of Surgical Oncology · 16
Molecular profiles of genomically high risk ER+ HER2- breast cancer tumors classified as functionally basal or luminal B by the 80-gene signature.
2021 · Joyce O'Shaughnessy, Virginia G. Kaklamani, et al. · Journal of Clinical Oncology · 3
Abstract PO4-02-02: Genomic Landscape of ER positive HER2-low early breast cancers in the FLEX Study: MammaPrint, BluePrint and whole transcriptome analysis
2024 · Abirami Sivapiragasam, Adam Brufsky, et al. · Cancer Research · 2
Abstract PS14-11: Differential gene expression analysis and clinical utility of MammaPrint and BluePrint in male breast cancer patients
2021 · Jennifer Crozier, Julie Barone, et al. · Cancer Research · 2
Correction to: Phase 2 Open-Label Trial Investigating Percutaneous Laser Ablation for Treatment of Early-Stage Breast Cancer: MRI, Pathology, and Outcome Correlations
2018 · Barbara Schwartzberg, John Lewin, et al. · Annals of Surgical Oncology · 2
PDF
Abstract P3-13-03: Multicenter clinical trial of percutaneous laser ablation for early stage primary breast cancer. Results of 49 cases with radiographic and pathological correlation
2016 · BS Schwartzberg, OMA Abdelatif, et al. · Cancer Research · 2
Subclavian Steal Syndrome
2000 · Raymond A. Dieter, Robert O. Maganini, et al. · Springer eBooks · 2
Abstract P2-08-12: Prediction of Chemotherapy Benefit by MammaPrint® in HR+HER2- Early Stage Breast Cancer Revealed by the FLEX Registry of Real World Data
2025 · Adam Brufsky, Kent Hoskins, et al. · Clinical Cancer Research · 1
FLEX, the 30,000 breast cancer transcriptome project: A platform for early breast cancer research using full-genome arrays paired with clinical data.
2022 · Cynthia X. Ma, Pat W. Whitworth, et al. · Journal of Clinical Oncology · 1
Abstract P2-08-26: FLEX: A Real-World Evidence, Full Transcriptome Study in 30,000 Patients with Early-Stage Breast Cancer
2025 · Robert Maganini, Ellis Levine, et al. · Clinical Cancer Research
Abstract P1-08-10: Germline BRCA1 and BRCA2 testing, Genetic Counseling and Adjuvant Therapy Patterns in Early Breast Cancer Patients
2025 · Mokica Izano, Kaitlyn Kane, et al. · Clinical Cancer Research
ASO Visual Abstract: The Clinical Utility of a 7-Gene Biosignature on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery: An Updated Analysis of the DCISionRT® PREDICT Study
2024 · Chirag Shah, Pat Whitworth, et al. · Annals of Surgical Oncology
PDF
Abstract PS18-04: Racial disparities in breast cancer and effect of obesity: MammaPrint, BluePrint and whole transcriptome analyses of tumors in Latin American patients in FLEX trial
2024 · Marcela Mazo-Canola, Virginia Kaklamani, et al. · Cancer Research
Abstract P5-03-03: Variant Classification Discordance: A real-world experience of genetic test results in a community-based setting
2023 · Shelly Cummings, Erin Mundt, et al. · Cancer Research
Abstract OT2-07-01: The FLEX real-world data platform explores new gene expression profiles and investigator-initiated protocols in early-stage breast cancer
2022 · Cynthia X. Ma, Robert Maganini, et al. · Cancer Research
Abstract OT-12-01: The FLEX real-world data platform explores new gene expression profiles and investigator-initiated protocols in early stage breast cancer
2021 · Laura Lee, Sami Diab, et al. · Cancer Research
Interstitial Laser Ablation as Alternative to Surgical Treatment of Benign Breast Tumors
2018 · Margaret Chen, Barbara S. Schwartzberg, et al. · Journal of the American College of Surgeons
Multicenter, phase II open-label trial of percutaneous laser ablation (PLA) for 61 patients (pts) with early-stage (ES) primary breast cancer: Radiographic (MRI) and pathological correlation.
2016 · Barbara Stewart Schwartzberg, Osama Abdelatif, et al. · Journal of Clinical Oncology
Works count: 22
Citation count: 247
H-index: 5
I10-index: 5
Year
Topic
Type